Design, Synthesis, and Renal Targeting of Methylprednisolone-Lysozyme

Methylprednisolone (MP) is often used in the treatment of various kidney diseases, but overcoming the systemic side effects caused by its nonspecific distribution in the body is a challenge. This article reports the design, synthesis, and renal targeting of methylprednisolone–lysozyme (MPS–LZM). Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Xingquan, Xie, Fei, Xiao, Dian, Zhou, Xinbo, Xiao, Junhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139590/
https://www.ncbi.nlm.nih.gov/pubmed/32168938
http://dx.doi.org/10.3390/ijms21061922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139590/
https://www.ncbi.nlm.nih.gov/pubmed/32168938
http://dx.doi.org/10.3390/ijms21061922

Ejemplares similares